Skip to main content
. 2022 Jun 2;13:883927. doi: 10.3389/fneur.2022.883927

Table 1.

Sociodemographic and clinical characteristics of the sample at T1.

Variablesa HC T2DM MDD BD SZ Statistical analyses
(n = 28) (n = 30) (n = 35) (n = 42) (n = 30) F(p)e Post hoc testg
Sociodemographic
Sexb, f, h 18(64%) 9(30%) 24(68%) 21(50%) 7(23%) 20.1**** SZ,T2DM < HC,MDD
SZ < BD
Age 36.6(14.5) 57.3(9.3) 47.3(11.8) 50.0(9.5) 40.8(10.7) 15.3**** HC < MDD,BD,T2DM
SZ,MDD < T2DM
SZ < BD
Years of education 16.1(3.3) 12.5(5.8) 11.9(4.3) 11.6(4.4) 10.4(3.3) 7.1**** SZ,BD,MDD,T2DM < HC
Clinical
BMI 24.9(5.1) 30.4(4.3) 28.6(5.8) 29.7(5.7) 31.9(5.4) 6.9**** HC < BD,T2DM,SZ
HDRSc 2.0(1.8) 3.9(3.9) 11.6(8.3) 6.4(4.4) 7.0(5.8) 14.2**** HC < BD,SZ,MDD T2DM,BD,SZ < MDD
YMRSc 0.8(1.6) 1.5(2.2) 1.9(2.6) 3.5(4.5) 3.2(4.9) 3.4** HC < BD
PANSS-Pc 7.0(0.0) 7.0(0.0) 7.0(0.3) 8.5(3.8) 10.6(4.3) 10.6**** HC,T2DM,MDD,BD < SZ
PANSS-Nc 7.0(0.0) 7.1(0.7) 8.4(4.9) 10.3(6.5) 18.6(10.1) 20.1**** HC,T2DM,MDD,BD < SZ
PANSS-Gc 16.0(0.0) 17.0(2.3) 19.8(8.6) 22.7(9.9) 31.8(12.7) 16.9**** HC,T2DM,MDD,BD < SZ
HC < BD
CGIc 1.9(1.0) 3.3(1.2) 3.5(0.7) 4.5(1.0) 31.3**** T2DM,MDD,BD < SZ
T2DM < MDD,BD
Age of onsetd 44.3(9.8) 35.3(12.1) 26.5(8.6) 25.6(8.0) 25.6**** SZ,BD < MDD,T2DM
MDD < T2DM
Illness durationd 13.0(9.0) 12.0(11.6) 23.4(11.5) 15.2(8.4) 9.6**** MDD,T2DM,SZ < BD
a

Expressed as mean (SD) except when indicated,

b

Female n (%).

c

Lower scores represent a better outcome.

d

Years.

e

ANOVA.

f

Chi-squared test.

g

Bonferroni test.

h

Mann–Whitney U test. T1, Time 1; HC, Healthy Control; T2DM, Type-2 Diabetes Mellitus; MDD, Major Depressive Disorder; BD, Bipolar Disorder; SZ, Schizophrenia; BMI, Body Mass Index; HDRS, Hamilton Rating Scale for Depression; YMRS, Young Mania Rating Scale; PANSS, Positive and Negative Syndrome Scale; P, Positive; N, Negative; G, General; CGI, Clinical Global Impression. ANOVA, Analysis of variance. NS, Not Significant.

(**

p ≤ 0.01;

****

p ≤ 0.0001).